<i>Background.</i> A novel mutation in the ACTG2 gene is described in a pregnant patient followed up for chronic intestinal pseudoobstruction (CIPO) during pregnancy and her fetus with megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS). This evidence concerns the gene ACTG2 and megacystis-microcolon-intestinal hypoperistalsis syndrome.